Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 5, 2024

https://www.prnewswire.com/news-releases/blueprint-medicines-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302027452.html

CAMBRIDGE, Mass., Jan. 5, 2024 /PRNewswire/ — Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective January 1, 2023, the Compensation Committee of Blueprint Medicines’ Board of Directors granted non-qualified stock options to purchase an aggregate of 9,393 shares of its common stock and an aggregate of 4,696 restricted stock units (RSUs) to two new employees under Blueprint Medicines’ 2020 Inducement Plan.

Read more at prnewswire.com

Related news for (BPMC)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.